MichaelGrundelIsonMDMS(He/Him)

Infectious Disease • Falls Church, VA

Chief, Respiratory Diseases Branch, DMID/NIAID/NIH

Join to view full profile

Dr. Ison is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Ison's full profile

Already have an account?

Office
3300 Gallows Rd
IHVI Heart Failure/Transplant
Falls Church, VA 22042
Phone+1 703-776-7075

Fax+1 703-776-2797

Summary

Dr. Michael Ison is an transplant infectious diseases specialist. He received his medical degree from University of South Florida Morsani College of Medicine and has been in practice 20 years. He is experienced in general infectious disease, kidney transplantation, liver transplantation, wound management, and respiratory tract infections. He has more than 100 publications and over 500 citings.

Education & Training

Massachussetts General Hospital/HMSTransplant Infectious Diseases, Transplant Infectious Diseases, 2004 - 2005
University of VirginiaMS, Health Evaluation Sciences, 2001 - 2004
University of Virginia Medical CenterFellowship, Infectious Disease, 2004
Oregon Health & Science University (OHSU Health)Residency, Internal Medicine, 1997 - 2000
University of South Florida College of MedicineClass of 1997

Certifications & Licensure

MD State Medical License 2023 - 2026
VA State Medical License 2001 - 2026
IL State Medical License 2005 - 2023
OR State Medical License 1999 - 2000
American Board of Internal Medicine Infectious Disease

Awards, Honors, & Recognition

Regional Top Doctor Castle Connolly, 2014
Super Doctor SuperDoctors.com

Clinical Trials

Safety and Efficacy of Investigational Anti-Influenza Immune Plasma in Treating Influenza Start of enrollment: 2010 Dec 01
Completed
Phase 2
Pharmacokinetic Assessment of Peramivir in Hospitalized Adults Undergoing Continuous Renal Replacement Therapy Start of enrollment: 2010 Feb 01
Withdrawn
Comparing the Efficacy, Safety, and Tolerability of Combination Antivirals (Amantadine, Ribavirin, Oseltamivir) Versus Oseltamivir for the Treatment of Influenza in Adults at Risk for Complications Start of enrollment: 2010 Sep 01
Completed
Phase 2
Evaluating the Use of Oseltamivir for the Treatment of Influenza in Adults Start of enrollment: 2011 Apr 01
Completed
Not Applicable
Clinical Evaluation of QFlu Combo Test Start of enrollment: 2010 Nov 01
Completed
Cell Mediated Immunity With Risk of Cytomegalovirus (CMV) in Solid Organ Transplant Recipients Start of enrollment: 2010 Apr 01
Completed
A Study of the Safety and Efficacy of CMX001 for the Prevention of CMV Infection in CMV-seropositive HCT Recipients Start of enrollment: 2013 Aug 01
Completed
Phase 3
Exploring Safety & Clinical Benefit of Anti-Influenza Immunoglobulin Intravenous in Hospitalized Adults With Influenza A Start of enrollment: 2017 Nov 17
Completed
Phase 2
NNITS-Nitazoxanide for Norovirus in Transplant Patients Study Start of enrollment: 2018 Oct 15
Completed
Phase 2
Join now to see all

Publications & Presentations

PubMed

Mycobacteroides abscessus outbreak and mitigation in a cardiothoracic transplant population: the problem with tap water.
S N Rathod, R T Weber, A A Salim, S D Tanna, V Stosor
The Journal of Hospital Infection. 2025-01-01
The Emerging Threat of H5N1 to Human Health.
Michael G Ison, Jeanne Marrazzo
The New England Journal of Medicine. 2024-12-31
Maribavir for refractory cytomegalovirus infection (with or without resistance) in solid organ transplant recipients: Subgroup analysis of the phase 3 randomized SOLST...
Emily A Blumberg, Oliver Witzke, Mark Harber, Michael G Ison, Faouzi Saliba
The Journal of Heart and Lung Transplantation. 2024-11-28

Journal Articles

Emergency Use Authorization of Remdesivir
Michael G Ison, Cameron Wolfe, Helen W Boucher, JAMA
Early Oseltamivir After Hospital Admission Is Associated with Shortened Hospitalization: A Five-Year Analysis of Oseltamivir Timing and Clinical Outcomes
Michael G Ison, Rachel Kohn, Clinical Infectious Diseases
Parainfluenza Virus in Hospitalized Adults: A 7-Year Retrospective Study
Michael G Ison, Elliott Russell, Clinical Infectious Diseases

Other

Parainfluenza viruses in adults
Ison MG
http://www.uptodate.com/contents/parainfluenza-viruses-in-adults
UpToDate, Wolters Kluwer Health - 2012-04-12

Authored Content

Emergency Use Authorization of RemdesivirMay 2020

Press Mentions

As Bird Flu Concerns Grow, Scientists Race to Develop New VaccinesJanuary 17th, 2025
New Reports Sharpen Clinical Picture of Recent Human H5N1 Illnesses in US and CanadaDecember 31st, 2024
As Pace and Severity of Human H5N1 Cases Accelerate, NIH Leaders Call for More Action on Bird FluDecember 31st, 2024
Join now to see all